Literature DB >> 21273480

Rapid pneumococcal evolution in response to clinical interventions.

Nicholas J Croucher1, Simon R Harris, Christophe Fraser, Michael A Quail, John Burton, Mark van der Linden, Lesley McGee, Anne von Gottberg, Jae Hoon Song, Kwan Soo Ko, Bruno Pichon, Stephen Baker, Christopher M Parry, Lotte M Lambertsen, Dea Shahinas, Dylan R Pillai, Timothy J Mitchell, Gordon Dougan, Alexander Tomasz, Keith P Klugman, Julian Parkhill, William P Hanage, Stephen D Bentley.   

Abstract

Epidemiological studies of the naturally transformable bacterial pathogen Streptococcus pneumoniae have previously been confounded by high rates of recombination. Sequencing 240 isolates of the PMEN1 (Spain(23F)-1) multidrug-resistant lineage enabled base substitutions to be distinguished from polymorphisms arising through horizontal sequence transfer. More than 700 recombinations were detected, with genes encoding major antigens frequently affected. Among these were 10 capsule-switching events, one of which accompanied a population shift as vaccine-escape serotype 19A isolates emerged in the USA after the introduction of the conjugate polysaccharide vaccine. The evolution of resistance to fluoroquinolones, rifampicin, and macrolides was observed to occur on multiple occasions. This study details how genomic plasticity within lineages of recombinogenic bacteria can permit adaptation to clinical interventions over remarkably short time scales.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273480      PMCID: PMC3648787          DOI: 10.1126/science.1198545

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

1.  Antibodies against PsrP, a novel Streptococcus pneumoniae adhesin, block adhesion and protect mice against pneumococcal challenge.

Authors:  Lloyd Rose; Pooja Shivshankar; Ernesto Hinojosa; Angela Rodriguez; Carlos J Sanchez; Carlos J Orihuela
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

2.  Emergence in Vietnam of Streptococcus pneumoniae resistant to multiple antimicrobial agents as a result of dissemination of the multiresistant Spain(23F)-1 clone.

Authors:  Christopher M Parry; Nguyen Minh Duong; Jiaji Zhou; Nguyen Thi Hoang Mai; To Song Diep; Le Quoc Thinh; John Wain; Nguyen Van Vinh Chau; David Griffiths; Nicholas P J Day; Nicholas J White; Tran Tinh Hien; Brian G Spratt; Jeremy J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi.

Authors:  Kathryn E Holt; Julian Parkhill; Camila J Mazzoni; Philippe Roumagnac; François-Xavier Weill; Ian Goodhead; Richard Rance; Stephen Baker; Duncan J Maskell; John Wain; Christiane Dolecek; Mark Achtman; Gordon Dougan
Journal:  Nat Genet       Date:  2008-07-27       Impact factor: 38.330

4.  Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization.

Authors:  Tera L McCool; Thomas R Cate; Elaine I Tuomanen; Peter Adrian; Tim J Mitchell; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

5.  Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae.

Authors:  R Muñoz; T J Coffey; M Daniels; C G Dowson; G Laible; J Casal; R Hakenbeck; M Jacobs; J M Musser; B G Spratt
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

6.  Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.

Authors:  Carmen Muñoz-Almagro; Iolanda Jordan; Amadeo Gene; Cristina Latorre; Juan J Garcia-Garcia; Roman Pallares
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

7.  Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae.

Authors:  Krzysztof Trzciński; Claudette M Thompson; Marc Lipsitch
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

Review 8.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

Authors:  Katherine L O'Brien; Lara J Wolfson; James P Watt; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Kim Mulholland; Orin S Levine; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

9.  Fluoroquinolone-resistant Streptococcus pneumoniae.

Authors:  Mathias W R Pletz; Randolph V Fugit; Lesley McGee; Jeffery J Glasheen; Darcie L Keller; Tobias Welte; Keith P Klugman
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883

10.  Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes.

Authors:  Stephen D Bentley; David M Aanensen; Angeliki Mavroidi; David Saunders; Ester Rabbinowitsch; Matthew Collins; Kathy Donohoe; David Harris; Lee Murphy; Michael A Quail; Gabby Samuel; Ian C Skovsted; Margit Staum Kaltoft; Bart Barrell; Peter R Reeves; Julian Parkhill; Brian G Spratt
Journal:  PLoS Genet       Date:  2006-03-10       Impact factor: 5.917

View more
  492 in total

1.  Multidrug-resistant Streptococcus pneumoniae serotype 6D clones in South Korea.

Authors:  Kwan Soo Ko; Jin Yang Baek; Jae-Hoon Song
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

2.  The role of postmortem studies in pneumonia etiology research.

Authors:  Gareth D H Turner; Charatdao Bunthi; Chizoba B Wonodi; Susan C Morpeth; Catherine S Molyneux; Sherif R Zaki; Orin S Levine; David R Murdoch; J Anthony G Scott
Journal:  Clin Infect Dis       Date:  2012-04       Impact factor: 9.079

Review 3.  The 2011 Garrod Lecture: From penicillin-binding proteins to molecular epidemiology.

Authors:  Brian G Spratt
Journal:  J Antimicrob Chemother       Date:  2012-03-28       Impact factor: 5.790

4.  A whole-genome single nucleotide polymorphism-based approach to trace and identify outbreaks linked to a common Salmonella enterica subsp. enterica serovar Montevideo pulsed-field gel electrophoresis type.

Authors:  Henk C den Bakker; Andrea I Moreno Switt; Craig A Cummings; Karin Hoelzer; Lovorka Degoricija; Lorraine D Rodriguez-Rivera; Emily M Wright; Rixun Fang; Margaret Davis; Tim Root; Dianna Schoonmaker-Bopp; Kimberlee A Musser; Elizabeth Villamil; Haena Waechter; Laura Kornstein; Manohar R Furtado; Martin Wiedmann
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

5.  Resolution of a meningococcal disease outbreak from whole-genome sequence data with rapid Web-based analysis methods.

Authors:  Keith A Jolley; Dorothea M C Hill; Holly B Bratcher; Odile B Harrison; Ian M Feavers; Julian Parkhill; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

Review 6.  Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.

Authors:  Richard Malley; Porter W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

Review 7.  Bacterial genomic epidemiology, from local outbreak characterization to species-history reconstruction.

Authors:  Stefano Gaiarsa; Leone De Marco; Francesco Comandatore; Piero Marone; Claudio Bandi; Davide Sassera
Journal:  Pathog Glob Health       Date:  2015       Impact factor: 2.894

Review 8.  Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens.

Authors:  Asma Hatoum-Aslan; Luciano A Marraffini
Journal:  Curr Opin Microbiol       Date:  2013-12-29       Impact factor: 7.934

9.  An outbreak of respiratory tularemia caused by diverse clones of Francisella tularensis.

Authors:  Anders Johansson; Adrian Lärkeryd; Micael Widerström; Sara Mörtberg; Kerstin Myrtännäs; Caroline Ohrman; Dawn Birdsell; Paul Keim; David M Wagner; Mats Forsman; Pär Larsson
Journal:  Clin Infect Dis       Date:  2014-08-05       Impact factor: 9.079

10.  Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein.

Authors:  Beth Mann; Justin Thornton; Richard Heath; Kristin R Wade; Rodney K Tweten; Geli Gao; Karim El Kasmi; John B Jordan; Diana M Mitrea; Richard Kriwacki; Jeff Maisonneuve; Mark Alderson; Elaine I Tuomanen
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.